BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190603
DTEND;VALUE=DATE:20190605
DTSTAMP:20260515T002214
CREATED:20190228T102509Z
LAST-MODIFIED:20190228T102724Z
UID:19778-1559520000-1559692799@www.pharmajournalist.com
SUMMARY:Lyophilisation
DESCRIPTION:SMi Presents their 7th Annual Lyophilisation Conference \nSMi Group announces the return of the 7th Annual Lyophilisation Conference taking place on the 3rd and 4th June 2019\, in London\, UK. \n \nLyophilisation (or freeze drying) remains one of the most exciting and rapidly advancing technologies in the pharmaceutical industry to date. By 2020\, the lyophilisation equipment market is projected to exceed 8% CAGR reaching approximately £4.4 billion. \nAttend this conference along with key opinion leaders from all areas of pharmaceuticals and biologicals to explore formulation science\, materials characterisation\, novel and alternative technologies\, mathematical modelling and regulatory updates. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019  \nSune Klint Andersen\, Principal Spray Drying\, Janssen Pharmaceuticals \nXiaodong Chen\, Senior Research Investigator\, Bristol-Myers Squibb \nKEY SPEAKERS INCLUDE: \n\nPaul Matejtschuk\, Principal Scientist & Section Head\, Standardisation Science\, NIBSC\nDavide Fissore\, Associate Professor\, Politecnico di Torino\nMichael Dekner\, Head Fill & Finish LCM support\, Takeda\nRichard Denk\, Head Sales Containment\, Skan AG\nMostafa Nakach\, Head of Pharmaceutical Engineering Group\, Sanofi-Aventis R&D\nDaryl Williams\, Professor of Particle Science and Director of Discovery space\, Imperial College London\nKevin Ward\, Director of R&D\, Biopharma technology\nPaul Barry\, Development Scientist\, Genzyme Ireland Ltd/Sanofi\n\n2019 HIGHLIGHTS \n\nExplore the recent advances in lyophilisation methods and technologies from Biopharma Technology\nDiscuss the novel methods that characterise complex pharmaceutical products to aid formulation design from NIBSC\nGain insight into the approaches to avoid cross contamination during lyophilisation from SKAN AG\nDiscover a new approach towards process design through the use of micro freeze dryers by Politecno di Torino\nExamine the use of model-based approach to lyophilisation cycle design from Takeda\n\nFor more information on 7th Annual Lyophilisation Conference\, visit: www.lyophilisation-europe.com/PJ \nEarly-Bird Rates \n\nBOOK BY 29TH MARCH AND SAVE £400\nBOOK BY 30TH APRIL AND SAVE £200\nBOOK BY 31ST MAY AND SAVE £100\n\nContact Info\nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/lyophilisation-conference-2019/
LOCATION:Holiday Inn Kensington Forum\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190604
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T002214
CREATED:20171216T022447Z
LAST-MODIFIED:20190404T074100Z
UID:5446-1559606400-1559865599@www.pharmajournalist.com
SUMMARY:Digital Pharma Europe
DESCRIPTION:The 11th Digital Pharma Europe\, hosted by Meck Serono in Rome\, will focus on helping pharma understand how to evolve and adapt to the rapidly changing global healthcare ecosystem\, and to the rapidly changing needs and dynamics of its customers. In essence: Understand Digital Marketing and the Evolution of The Engagement Model In The Era of AI. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2UrQr1e
URL:https://www.pharmajournalist.com/event/digital-pharma-europe/
LOCATION:Merck Serono Headquarters\, Via Casilina 125\, Rome\, 00176\, Italy
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190605
DTEND;VALUE=DATE:20190607
DTSTAMP:20260515T002214
CREATED:20190522T081845Z
LAST-MODIFIED:20190522T081845Z
UID:20818-1559692800-1559865599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply Southern California 2019
DESCRIPTION:Facilitating a platform for the San Diego biotech hub to refine their clinical trial supply strategy to remain patient focused whilst staying at the forefront of an ever-changing landscape. \n2019 will celebrate the 9th year Arena International brings the global Clinical Trial Supply series to San Diego\, giving decision makers from small\, medium and large pharmaceutical companies the opportunity to as inject agility\, transparency and speed into your clinical trial supply. \nThis event brings the unique San Diego biotech hub together to discuss the best methodologies for ensuring successful clinical trial supply. We will focus on the full supply chain\, starting with the front end all the way to site and direct to patient delivery. Delving into the finer details we will ensure the smooth running of trial supplies\, to not only start and finish on time\, but also to meet budgetary constraints. \nAvoiding death by power point our 2 day event will facilitate interactive and engaging sessions from panel discussions\, roundtables\, fireside chats and case studies to give rise to innovation solutions to existing challenges. \nThe key topics to be addressed will be: \n\nForecasting and Planning\nPackaging and Labelling\nUnique trial design e.g. adaptive\, compassionate use and at home delivery\nBrexit\nNew technologies\n\nJoin us in June in San Diego to be a part of the discussions and develop unique insight for clinical trial supply.
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-southern-california-2019/
LOCATION:Marriot Del Mar\, San Diego\, California
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190618
DTEND;VALUE=DATE:20190621
DTSTAMP:20260515T002214
CREATED:20181113T085750Z
LAST-MODIFIED:20181128T092809Z
UID:18371-1560816000-1561075199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2019
DESCRIPTION:As the most comprehensive pharmaceutical exhibition in Asia\, CPhI & P-MEC China has\, since its launch in 2001\, been fostering international pharmaceutical business exchanges and leading market trends and technical innovations in the entire industry. Based in Shanghai and with a global vision\, CPhI & P-MEC China is emanating its influences by creating a trading & sourcing platform\, gathering quality suppliers\, sharing cutting-edge knowledge\, and building up an elite pharma professional network. \n \nCPhI & P-MEC China 2019 will be held in Shanghai on June 18-20\, 2019. The annual pharma gala are expected to gather 70\,000+ visits and showcase 3\,200+ exhibitors in a 200\,000+ square metre space. Welcome to join us in CPhI & P-MEC China 2019! \n  \nTo learn more and to register online\, visit: http://bit.ly/2r8jnuD
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2019/
LOCATION:SNIEC\, Shanghai\, China
ORGANIZER;CN="UBM":MAILTO:Yingqi.shi@ubmsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190619
DTEND;VALUE=DATE:20190622
DTSTAMP:20260515T002214
CREATED:20190220T075016Z
LAST-MODIFIED:20190220T075016Z
UID:19657-1560902400-1561161599@www.pharmajournalist.com
SUMMARY:8th Annual HPAPI Summit
DESCRIPTION:Enabling Robust\, Safe and Cost-Effective Productionof Highly Potent APIs \nIn the context of ever-increasing drug potency\, the 8th Annual HPAPI Summit will provide you with real-world case-studies from the companies actively working with these compounds\, enabling you to implement safe and robust practices in your own organization. \nIncorporating insights from Genentech\, Pfizer\, Boehringer Ingelheim\, SafeBridge and AbbVie\, you will leave this conference with actionable insights that will enable you to produce highly potent APIs more robustly\, safely and cost-effectively.
URL:https://www.pharmajournalist.com/event/8th-annual-hpapi-summit/
LOCATION:The Westin Waltham Boston  70\, Third Avenue  Waltham\,Boston  Massachusetts 02451
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190624
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T002214
CREATED:20190326T120821Z
LAST-MODIFIED:20190326T121125Z
UID:20086-1561334400-1561593599@www.pharmajournalist.com
SUMMARY:GI Inflammatory Diseases Summit (GIIDS)
DESCRIPTION:Developing More Clinically Safe & Efficacious Therapeutics for GI Inflammatory Diseases \nThe GI Inflammatory Diseases Summit (GIIDS) focuses exclusively on overcoming translational drug development challenges to achieve more clinically safe and efficacious therapeutics for Inflammatory Bowel Disease. \nIncorporating insights from leading pharma and pioneering biotech\, this discussion and networking forum will curate the cutting edge insights on: \n\nImproving drug safety profiles of more gut-selective compounds\nOptimizing trial design in a hypercompetitive market\nThe promise of microbiome based biotherapeutics\n\nJoin gastroenterology\, immunology and anti-inflammatory drug developers at this unique conference and push the clinical frontier nearer to achieving significant clinical remission in larger groups of patients.
URL:https://www.pharmajournalist.com/event/gi-inflammatory-diseases-summit-giids/
LOCATION:Revere Hotel Boston Common  200 Stuart Street  Boston\, MA\, 02116  USA\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260515T002214
CREATED:20190418T090640Z
LAST-MODIFIED:20190418T090640Z
UID:20372-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:2nd Combination Products Lifecycle Management Summit
DESCRIPTION:Returning to Boston for its 2nd successful year in 2019\, the CPLM Summit features a fresh speaker line-up including the FDA\, Alnylam\, kaleo\, Novartis and many others\, as well as a pre-conference focus day to give you a comprehensive LCM guide to your combination products. \n \nLifecycle management for drug-device combination product has stolen the spotlight amongst pharma\, biotechs and device developers. Integrating multiple project teams and defining a common LCM program can be difficult – but there is a lot of potential and many benefits to having such a mind-set and implementing a robust LCM program from the get-go. \nAs the only peer-led community\, we will bring in 100+ senior leaders from drug-device teams including the regulatory affairs\, product development and quality to share their view and encourage collaborative efforts. \nFor more information on 2nd Annual CPLM Summit\, visit https://ter.li/11hr26
URL:https://www.pharmajournalist.com/event/2nd-annual-cplm-summit/
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190625
DTEND;VALUE=DATE:20190628
DTSTAMP:20260515T002214
CREATED:20190426T082151Z
LAST-MODIFIED:20190426T082638Z
UID:20510-1561420800-1561679999@www.pharmajournalist.com
SUMMARY:Cell Engager Summit
DESCRIPTION:The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic. \n \nOvercome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug. \nDiscover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies. \nWith 22+ hours of content\, 2 interactive workshops and over 5 hours of networking with key industry leaders\, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges. \nJoin us as we unite experts from across large pharma\, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies. \nTo learn more and to register online\, visit cell-engager-summit.com
URL:https://www.pharmajournalist.com/event/cell-engager-summit/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190629
DTSTAMP:20260515T002214
CREATED:20190225T142502Z
LAST-MODIFIED:20190225T142702Z
UID:19737-1561507200-1561766399@www.pharmajournalist.com
SUMMARY:4th Microbiome Movement – Drug Development Summit
DESCRIPTION:4th Microbiome Movement – Drug Development Summit\nJune 26-28\, 2019 | Boston\, MA \n \nReturning for the fourth year\, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical\, biotech and academic community pursue the causal role of the human microbiome in disease\, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs. \nIf you are\, or would like to be\, a player in the microbiome arena\, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics\, biomarkers and diagnostics\, but also make long-lasting connections that will accelerate your microbiome developments forward\, and help translate this promising science into a reality for patients. \nHear from 60+ expert speakers including: \n\nAlison Lawton\, CEO\, Kaleido Biosciences\nBernat Olle\, CEO\, Vedanta Biosciences\nCathryn Nagler\, Bunning Food Allergy Professor\, University of Chicago\nEric Shaff\, CEO\, Seres Therapeutics\nEsi Lamouse-Smith\, Director\, Janssen Pharmaceuticals\nKen Blount\, CSO\, Rebiotix\nMike Romanos\, CEO\, Microbiotica\nUlrich Thienel\, Chief Medical Officer\, Finch Therapeutics Group\n\nSee the complete agenda and speaker list: https://ter.li/nefsqj \nEarly booking rates and group discounts are available. Visit the website to learn more: https://ter.li/1bcb5n.
URL:https://www.pharmajournalist.com/event/4th-microbiome-movement-drug-development-summit/
LOCATION:Revere Boston Common Hotel\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20260515T002214
CREATED:20190409T072829Z
LAST-MODIFIED:20190409T072829Z
UID:20257-1561507200-1561593599@www.pharmajournalist.com
SUMMARY:The Pharma Gorilla
DESCRIPTION:After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27\, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.  \n\nThe Pharma Gorilla | June 26\, 2019 | Le Meridien Singapore\, Sentosa\nThe Pharma Gorilla | Nov 07\, 2019 | New Delhi\, India\n\n The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends\, advancements\, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry. \nThe conference program have been designed in such way which can cover the trending topics under Keynote session\, exclusive presentation\, product lunch\, panel and round table discussion and it also provides a meaningful information. \nThe Pharma Gorilla provides a perfect platform for conducting presentations\, keynote sessions\, sharing the knowledge\, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition. \nTarget Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies\, software development companies\, CRO\, manufacturing\, formulation\, digital marketing and data management companies. \nGlimpse of Conference Agenda! \n Conference Panels \n\nArtificial Intelligence in Pharma and Healthcare\nA disruptive take on marketing: Digital Marketing comes to Pharma\nScope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry\nLatest Trends in Formulation Development: A Global Perspective\nThe Impact of Regulatory Reform on Innovation in Drug Delivery Systems\n\nRoundtable Discussion \n\nImproving patient engagement and experience to improve clinical trials\n\n Keynote Session \n\nInnovation-driven and emerging technologies of Pharma Industry in Asia\nThe Global Pharma Industry: Policies\, Regulations and Key Trends 2019-2020\n\nExclusive Presentation \n\nRole of IPR in pharmaceutical industry\nCareer Growth Opportunities in the pharmaceutical industry\nImproving Biosimilars in manufacturing data\n\nFor any query\, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588
URL:https://www.pharmajournalist.com/event/the-pharma-gorilla-2/
LOCATION:Le Meridien Singapore\, Sentosa
ORGANIZER;CN="The Conference Gorilla":MAILTO:contact@theconferencegorilla.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190710
DTEND;VALUE=DATE:20190712
DTSTAMP:20260515T002214
CREATED:20190522T082202Z
LAST-MODIFIED:20190522T082202Z
UID:20825-1562716800-1562889599@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials to East Coast 2019
DESCRIPTION:Arena International is excited to announce the return of the 7th Annual Clinical Operations in Oncology Trials to the East Coast on July 10th-July 11th 2019. \nAs one of the only oncology operationally focused events in the East Coast\, this meeting will aim to provide strategies to allow for operationally meaningful and targeted oncology trials to engage East Coast physicians and patients. \nThe event will be led by a myriad of industry specialists from the East Coast who will deliver solution and strategy through a variety of interactive formats: panel discussion\, spotlight Q&As\, roundtables and more! This conference will also provide a platform for industry professionals to network with some of the most innovative vendors in the market. \nWhile maintaining the primary focus of its previous years\, our 2019 event will look at how to prepare for the ever-changing dynamic of the oncology industry\, and provide insight into the latest technological and therapeutic solutions. \nThis July prepare to hear from  industry leading oncologists about accurate abidance to ICH E8 guidelines\, effective oversight strategies\, efficient trial designs and data management solutions. As pharmaceutical companies shift to conducting immuno-oncology trials and look towards how AI\, data analytics and cutting edge technology can aid with early diagnosis\, take this opportunity to stay updated with industry trends and showcase your innovative solutions to key decision makers. \nWe hope to see you in July\, make sure to register your place today!
URL:https://www.pharmajournalist.com/event/clinical-operations-in-oncology-trials-to-east-coast-2019/
LOCATION:Boston\, Massachusetts
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T002214
CREATED:20190204T112557Z
LAST-MODIFIED:20190204T113033Z
UID:19372-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:Indian Pharma Expo & Business Excellence Award 2019
DESCRIPTION:CIMS Medica presents the 8th edition of Indian Pharma Expo (IPE)\, scheduled to be held on 16th-18th July\, 2019 at Hall No. 12-A\, Pragati Maidan\, New Delhi. \n \nPrevious year IPE set another successful milestone with presence of visitors from all parts of India and provided a common platform for promising sellers and potential buyers from Pharmaceutical and Healthcare Industries. With IPE\, the benefits are bound to get augmented with presence of eminent personalities from various sectors of Pharma\, non-pharma and healthcare industries. It will gather representation from various companies like Pharmaceutical manufacturers & marketers\, packaging solution providers\, machinery solution providers\, franchise companies and many more under one roof. \nThe 3-day expo will bring together eminent personalities from various sectors of Pharmaceutical\, non-pharma and healthcare industries. IPE 2019 is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnel who seek to buy bulk products on concessional rates. \nThis year IPE will be one point contact to exchange the business opportunities for National and International Pharmaceutical Companies. This event will prove to be a business expansion tool to many small-medium-major players in Pharmaceutical Industry.
URL:https://www.pharmajournalist.com/event/indian-pharma-expo-business-excellence-award-2019/
LOCATION:Hall no. 12-A\, Pragati Maidan\, New Delhi\, Delhi\, India
ORGANIZER;CN="CIMS Medica India Pvt Ltd":MAILTO:ipe@cims.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T002214
CREATED:20190424T121423Z
LAST-MODIFIED:20190424T121423Z
UID:20441-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:PREDiCT: Tumor Models Boston
DESCRIPTION:The 7th Annual PREDiCT: Tumor Models Boston summit will explore robust preclinical strategies utilizing current and emerging model systems to overcome core challenges across the early stages of cancer drug development. Presentations will span preclinical strategies validating new anticancer drugs\, assessing therapeutic index and identifying surrogate markers of tumor progression. \n \nPlug into a network of preclinical and translational scientists seeking to share methods for the rational design of combinations\, patient stratification and identify new strategies to model metastasis\, resistance and sensitivity. \nWhy attend PREDiCT : Tumor Models Boston ? \n\n35+ Preclinical & Translational Oncology Heads\, each pioneering the further development and application of experimental models\, will be sharing the latest insights on the impact of their work.\n100+ senior level scientists from Sanofi\, Kleo Pharmaceuticals\, NIH\, Dicerna\, Pfizer\, Crown Bioscience\, The Jackson Laboratory\, Eisai and many more are set to review the comparative cost-per-data point of next generation models alongside classical model-systems.\nWe’ll explore how classical and emerging models are evolving efficacy determination\, biomarker discovery and combination therapies\, allowing you to further develop your research and gain the best insight of the industry.\n\nDownload the full event guide to find out more! \nTo learn more about this event\, and to register online\, visit https://tumor-models.com/
URL:https://www.pharmajournalist.com/event/predict-tumor-models-boston/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190716
DTEND;VALUE=DATE:20190719
DTSTAMP:20260515T002214
CREATED:20190617T102853Z
LAST-MODIFIED:20190617T102853Z
UID:21229-1563235200-1563494399@www.pharmajournalist.com
SUMMARY:IMPACCT: mHealth in Clinical Trials Summit
DESCRIPTION:The IMPACCT: mHealth in Clinical Trials series provides a dedicated forum for industry leaders in clinical and digital innovation to share data\, best practice and game-changing approaches on how to transform the clinical research paradigm with digital technology and achieve true patient-centricity. \nJoin your peers and leading experts in this space for a collaborative discussion aiming to tackle key implementation challenges and accelerate the successful incorporation of innovative digital strategies in clinical R&D\, to enhance patient experience and outcomes. \nIndustry leaders already confirmed include Novartis\, AbbVie\, the DiMe Society\, Verily & many others.
URL:https://www.pharmajournalist.com/event/impacct-mhealth-in-clinical-trials-summit/
LOCATION:The Westin Copley Place Boston\, 10 Huntington Ave\, Boston\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190723
DTEND;VALUE=DATE:20190726
DTSTAMP:20260515T002214
CREATED:20190404T071545Z
LAST-MODIFIED:20190404T071545Z
UID:20177-1563840000-1564099199@www.pharmajournalist.com
SUMMARY:2nd Neuropsychiatric Drug Development Summit
DESCRIPTION:THE INDUSTRY’S DEFINITIVE MEETING TO ADVANCE THE DEVELOPMENT OF CLINICALLY TRANSFORMATIVE NEUROPSYCHIATRIC DRUGS \n \nWith the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available\, the development of the next generation of neuropsychiatric drugs is essential. \nThe abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the Neuropsychiatric Drug Development summit\, in Boston on July 23 – 25\, 2019. \nBuilt with thought-leaders at Sage Therapeutics\, Johnson & Johnson and Lundbeck\, the 2nd Annual NPD summit will unravel the complexities of developing truly clinically transformative neuropsychiatric drugs. \nDedicated to overcoming challenges in neuropsychiatric drug development\, this comprehensive discussion and networking forum will cover: \n\nReviewing the current clinical landscape to share learned lessons\, predict potential success and identify future opportunities\nDetermine what we can expect from neuropsychiatric preclinical models to better predict clinical efficacy\nUtilize what we know from the clinical to improve our use of translational strategies\nDiscuss the potential for digital therapeutics to transform the success of efficacious pharmaceuticals\nReview symptomatic focused drug development to identify the benefits and impact future regulation\nEvaluate the potential for different neuropsychiatric targets by improving our understanding of neuropsychiatric biology\nImproving our understanding of the role of genetics in neuropsychiatry and debating the future of precision medicine for neuropsychiatric disorders\n\nJoin your peers at NPD to be part of the cross-industry discussion on latest developments\, insights and science to elevate clinically effective neuropsychiatric therapeutic pipelines \nTo learn more about this event\, visit https://ter.li/belugv
URL:https://www.pharmajournalist.com/event/2nd-neuropsychiatric-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190813
DTEND;VALUE=DATE:20190816
DTSTAMP:20260515T002214
CREATED:20190530T091644Z
LAST-MODIFIED:20190530T091644Z
UID:20938-1565654400-1565913599@www.pharmajournalist.com
SUMMARY:B3DD Summit
DESCRIPTION:The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates. \n \nWith an emphasis on biologics\, and built with the field’s leading minds from the likes of Biogen\, Genentech\, Armagen & Denali\, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development. \nSome of the highlights include: \n\nAssessing Microphysiological Models of the BBB – Biogen\nEmploying in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie\nClinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I\nPKPD of Different Therapeutic Modalities for CNS Indications – Genentech\nExplaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck\, Lundbeck\, AbbVie\n\nTo learn more about B3DD Summit\, and to register online\, visit https://ter.li/7vs04e
URL:https://www.pharmajournalist.com/event/b3dd-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190820
DTEND;VALUE=DATE:20190823
DTSTAMP:20260515T002214
CREATED:20190529T091738Z
LAST-MODIFIED:20190529T091738Z
UID:20911-1566259200-1566518399@www.pharmajournalist.com
SUMMARY:2nd Annual Hemophilia Drug Development Summit
DESCRIPTION:Given the excitement and anticipation of increasingly more promising prophylactic treatments and gene therapies\, the 2nd Annual Hemophilia Drug Development Summit\, once again unites leading pharma\, biotech and academic KOLs working to translate and clinically develop longer acting and more efficacious therapies to overcome significant unmet medical need and hemophilia and other bleeding disorders. \n \nAttend the 2nd Hemophilia Drug Development Summit to identify novel drug development strategies and overcome the shared translational\, clinical development and delivery challenges to dramatically improve patient outcomes. \nSounds interesting? Find out more – get free event brochure here: https://ter.li/4snxn9
URL:https://www.pharmajournalist.com/event/hemophilia-drug-development-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190822
DTEND;VALUE=DATE:20190824
DTSTAMP:20260515T002214
CREATED:20190531T125458Z
LAST-MODIFIED:20190531T125545Z
UID:21020-1566432000-1566604799@www.pharmajournalist.com
SUMMARY:4th Annual Medical Device Regulatory and Quality Summit 2019
DESCRIPTION:4th Annual Medical Device Regulatory and Quality Summit 2019 will create a platform for regulators\, industry stalwarts to come under one roof to discuss and share ideas that would not only benefit their organisations\, but at large the industry as well. The 4th Annual Medical Device Regulatory and Quality Summit 2019 will review the evolving regulations\, their impact on the industry as well as take an in depth look into areas of quality control and assurance. \n \nTo learn more about this event\, and to register online\, visit http://bit.ly/2MgH15z
URL:https://www.pharmajournalist.com/event/4th-annual-medical-device-regulatory-and-quality-summit-2019/
LOCATION:New Delhi\, India
ORGANIZER;CN="Inventicon Business Intelligence":MAILTO:pooja.mishra@inventicon.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190827
DTEND;VALUE=DATE:20190830
DTSTAMP:20260515T002214
CREATED:20180531T135859Z
LAST-MODIFIED:20190430T084109Z
UID:16049-1566864000-1567123199@www.pharmajournalist.com
SUMMARY:3rd Annual IPF Summit
DESCRIPTION:The IPF Summit focuses exclusively on closing the translational gap between preclinical predictability and clinical attrition to accelerate the development of truly curative idiopathic pulmonary fibrosis (IPF) therapeutics. \n \nWith the 2019 conference expanding upon an even greater breadth and depth of content\, you’ll hear three days of unrivalled scientifically driven and case-study based analysis and discussion\, as together leading academia and biopharma advance the IPF drug development frontier. \nLast year\, over 90 of IPF’s expert drug developers came together to advance the standardisation of imaging\, share clinical insights\, and evaluate better recapitulating disease physiology in vitro exclusively for IPF: \n“This was a superb meeting combining several emerging themes in IPF therapies and a dynamic mix of formal presentations with impromptu networking. All the speakers were excellent\, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!” \nCeders-Sinai Medical Center \nWith the incredible breakthrough success of drugs now in our arsenal for slowing IPF disease progression\, the increasing importance of identifying genetic mechanisms\, closing the translational gap between preclinical and clinical results\, and developing candidates to reverse fibrosis have opened up further challenges within IPF drug development. \nJoin “part 3” as the IPF community converges again to: \n\nAnalyze the latest understanding of IPF pathology for improved target validation of next generation therapeutics and the potential to promote tissue regeneration to achieve reversal of fibrosis\nCritically discuss how to design the next generation of phase III clinical trials for candidate success in light of a current standard of care\nOutline progressions in the standardization of imaging and advancements of biomarkers to improve translational success and more confident diagnosis of patients\n\nTo learn more about 3rd Annual IPF Summit and to register online\, visit https://ter.li/i81anp \nContact \nEmail – info@hansonwade.com\nPhone – +1 415 735 3289
URL:https://www.pharmajournalist.com/event/ipf-summit/
LOCATION:Sheraton San Diego Hotel & Marina\, 1380 Harbor Island Drive\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T002214
CREATED:20190529T085545Z
LAST-MODIFIED:20190529T090758Z
UID:20888-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:2nd Microbiome Movement - Skin Health & Dermatology Summit
DESCRIPTION:2nd Microbiome Movement – Skin Health & Dermatology Summit\nTranslate the Skin Microbiome into Safe\, Effective & Commercially Viable Dermatological Therapeutics & Cosmetic Products\n4-6 September 2019 | San Diego\nWebsite: https://ter.li/bsl3rt \nAs scientific researchers continue to investigate the complexities of the skin microbiome\, our mission for the 2nd Microbiome Movement – Skin Health & Dermatology Summit is simple: Build a collaborative forum that unites forward thinking academic\, dermatological & cosmetic researchers\, and lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing solutions that modify the skin microbiome to treat disease (therapeutics) or support overall skin health (cosmetics). \n \nOur conversations have highlighted that although a strong commercial opportunity exists\, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions\, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis. \nIf you’re keen to make sense of skin microbiome science and its application to the therapeutic and cosmetic industry\, join over 100+ scientifically-driven researchers from academia\, biopharma and the cosmetic community to help you discover\, translate and commercialize breakthrough therapeutics or cosmetics that improve skin health. \nEarly booking and group discounts are available. Visit the website to learn more: https://ter.li/bsl3rt
URL:https://www.pharmajournalist.com/event/2nd-microbiome-movement-skin-health-dermatology-summit/
LOCATION:The Westin San Diego\, 400 West Broadway\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190904
DTEND;VALUE=DATE:20190907
DTSTAMP:20260515T002214
CREATED:20190708T094531Z
LAST-MODIFIED:20190708T094531Z
UID:21492-1567555200-1567814399@www.pharmajournalist.com
SUMMARY:3D Tissue Models Summit
DESCRIPTION:The 3D Tissue Models Summit will bring together 120+ industry stakeholders across the regulatory\, pharma\, biotech and academic landscapes to discuss the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates. \nJoin us and discover: \n20+ latest case studies showcasing the advantages of high throughput screening techniques across the 3D model continuum to drive drug discovery progress. \nFDA guidance into the regulatory landscape to define a common language of key terms across the industry for end users. \nNIH and IQ Consortia discussing the latest developments to incorporate platform-specific standardization and reproducibility metrics for organoids and tissue chip technology. \nModel developers and academic experts revealing how to overcome translational challenges to define disease-relevant endpoints across a variety of model types. \nTake advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.
URL:https://www.pharmajournalist.com/event/3d-tissue-models-summit/
LOCATION:Hilton Boston Back Bay  40 Dalton St  Boston\, MA  02115\, USA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190912
DTSTAMP:20260515T002214
CREATED:20190522T082604Z
LAST-MODIFIED:20190522T082604Z
UID:20829-1568073600-1568246399@www.pharmajournalist.com
SUMMARY:Pharma and Device Packaging and Labelling Europe 2019
DESCRIPTION:After a successful European launch\, a special thank you to all our attendees at the Pharma Packaging and Labelling Conference! Arena International is delighted to announce we will be returning to Munich in 2019 for another superb year. \nWe have welcomed more than 100 attendees from across the region for two days of engaging presentations from the biggest names in the sector. \nThe 2018 programme looked at ongoing regulations\, ensuring patient safety and making sure the right systems are in place which is more crucial than ever with the ever looming FMD regulations. Top pharmaceutical companies\, biotechs\, CMOs and medical device companies such as Abbott\, Sandoz\, Coloplast\, AbbVie\, Novartis\, Roche; including regulatory bodies GS1\, EAASM and many more came together to share their insights into compliant packaging and labelling implementation. \nPharma Packaging and Labelling Europe will be returning in September 2019. We look forward to seeing you all there!
URL:https://www.pharmajournalist.com/event/pharma-and-device-packaging-and-labelling-europe-2019/
LOCATION:Munich\, Germany
ORGANIZER;CN="Arena International":MAILTO:events@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190910
DTEND;VALUE=DATE:20190914
DTSTAMP:20260515T002214
CREATED:20190607T133410Z
LAST-MODIFIED:20190607T133524Z
UID:21126-1568073600-1568419199@www.pharmajournalist.com
SUMMARY:5th Annual CAR-TCR Summit
DESCRIPTION:The definitive\, world-renowned summit dedicated to providing comprehensive insight into the full end-to-end pharmaceutical value chain for CAR-TCR therapies in liquid and solid tumor indications. \nThe CAR-TCR Summit remains at the forefront of the industry bringing you never-seen-before data from the movers and shakers in CAR and TCR therapy development. \n \nDedicated to discussing the next generation candidates beyond CD19\, from solid tumor indications to autoimmune disorders\, this meeting provides an in depth breakdown of the current strategies to optimize the durability\, persistence and targeting of approved and novel therapies to reduce relapse rates and overcome toxicity. \nAt the premier\, end-to-end summit focused on early research through to commercialization\, join the experts to discuss how to streamline process development and logistics supply chains for affordable and accessible CAR-TCR therapeutics. \nTake advantage of the unrivalled networking opportunities as we bring together over 1000 industry leaders developing CAR-TCR based therapies from across pharma\, biotech\, regulatory bodies\, academia\, solution and service providers. \nHere’s a snapshot of the 140+ world class speaker faculty: \n\nJames Noble\, Chief Executive Officer\, Adaptimmune\nBarbra Sasu\, Chief Scientific Officer\, Allogene\nChris Haqq\, Chief Scientific Officer\, Atara Biotherapeutics\nElsy Boglioli\, Chief Operating Officer\, Cellectis\nJean-Pierre Latere\, Chief Operations Officer\, Celyad\nKatherine Szarama\, Evidence Development Division\, Coverage & Analysis Group\, Center for Clinical Standards and Quality\, Centers for Medicare & Medicaid Services\nCheng Liu\, Chief Executive Officer\, Eureka Inc.\nJason Krentz\, Chief Technology Officer\, Tmunity Therapeutics\nThomas Andresen\, Chief Scientific Officer\, Torque Therapeutics\nMatthew Spear\, Chief Medical Officer\, Poseida Therapeutics\n\nDownload the event guide for the full details of the speaker line-up\, agenda and discounts available.
URL:https://www.pharmajournalist.com/event/5th-annual-car-tcr-summit/
LOCATION:Seaport Hotel & World Trade Center\, One Seaport Lane\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190916
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T002214
CREATED:20190213T095145Z
LAST-MODIFIED:20190214T154239Z
UID:19528-1568592000-1568937599@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics Digital Week
DESCRIPTION:4-day complimentary series of live educational webcasts and downloadable resources uncovering insights to accelerate oligonucleotide and peptide products from early discovery to commercialization. \n \nWhy Attend A Webinar?\n \n\nTime and Cost Efficient\nYou will save valuable time and money because there is no need to travel and no registration fee.\nFocused and Timely Learning\nYou will receive the latest “hot” and timely data from a leading authority\nConvenience\nYou can participate in a webinar from a location of your choosing – your home\, your office\, or a client/customer location\n\nSign up now: www.TIDESDigitalWeek.com
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics-digital-week/
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190917
DTEND;VALUE=DATE:20190919
DTSTAMP:20260515T002214
CREATED:20190529T090623Z
LAST-MODIFIED:20190529T090623Z
UID:20904-1568678400-1568851199@www.pharmajournalist.com
SUMMARY:Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit
DESCRIPTION:Inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit\nAdvance the Next Generation of Safe\, Effective & Commercially Viable Microbiome-Based Therapeutics & Nutritional Products\n17-18 September 2019 | Singapore\nWebsite: https://ter.li/tf7voy \n \nPart of the globally recognised Microbiome Movement\, we are delighted to announce the arrival of the inaugural Microbiome Movement – Drug Development & Nutrition Asia Summit to help translational microbiome researchers in APAC discover\, develop and deliver the future generation of microbiome-based products across therapeutic and nutritional industry applications. \nThis year’s forum will play an important role in reviewing the major scientific and commercial progress areas in microbiome research in APAC but also help you stimulate new business opportunities in a new and exciting field. Join and interact with industry and academic key opinion leaders from Asia’s prominent microbiome-focused organisations at this year’s forum to accelerate your knowledge of the field\, overcome key challenges in translating your microbiome research to commercial reality and help deliver a new future for healthcare. \nEarly booking and group discounts are available. Visit the website to learn more: https://ter.li/tf7voy
URL:https://www.pharmajournalist.com/event/drug-development-nutrition-asia-summit/
LOCATION:Hilton Singapore\, 581 Orchard Rd\, 238883\, Singapore
ORGANIZER;CN="Hanson Wade":MAILTO:info@microbiome-movement.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190917
DTEND;VALUE=DATE:20190921
DTSTAMP:20260515T002214
CREATED:20190705T113213Z
LAST-MODIFIED:20190708T075127Z
UID:21440-1568678400-1569023999@www.pharmajournalist.com
SUMMARY:13th Digital Pharma East
DESCRIPTION:The 13th Digital Pharma East\, http://bit.ly/307A0WT\,  returns to the Pennsylvania Convention Center\, September 17-20. Discover how you can present business plans\, justify budget\, innovation and de-risk proposals when you join us for this annual event. Register with Discount Code DPE19PJ to secure your seat\, http://bit.ly/2xsmS2a. \nMake sure to download the brochure to see what’s on the agenda: http://bit.ly/2Jak8gN
URL:https://www.pharmajournalist.com/event/13th-digital-pharma-east/
LOCATION:Pennsylvania Convention Center
ORGANIZER;CN="ExL Events%2C a division of Questex%2C LLC":MAILTO:exlcontact@questex.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T002214
CREATED:20190613T103849Z
LAST-MODIFIED:20190613T111335Z
UID:21149-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:7th Annual IMPACCT: RWE
DESCRIPTION:Returning for its 7th year\, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle\, from clinical development to commercialization. \nJoin your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes\, drive patient-centricity\, and maximize the success of launch and commercialization activities. \nReal world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs\, drug developers are now able to drive more patient-facing outcomes\, by supporting it with effective evidence-based decision-making across the product life cycle. \nAt a point of increasing maturity\, regulatory acceptance\, and growing innovation\, these are exciting times for all stakeholders actively involved in the efforts to advance the effective utilization and generation of real world evidence. \nLeading experts in the space will be tackling questions and sharing the latest case-studies around the use of RWE in: \n\nPatient identification\nClinical trial design\nHistoric control arms\nOutcomes research\nObservational research\nPost-launch safety studies\nDefining medical affairs strategy\nValue generation across the product life cycle\nRegulatory decision-making\nLabel extensions\nPatient access\n\n… and more. \nJoin them at this collaborative discussion platform that aims to bring together stakeholders from functions across clinical development\, HEOR\, regulatory and medical affairs\, epidemiology and RWE\, to overcome key challenges to define and implement a meaningful evidence generation plan that can effectively enhance clinical R&D\, support regulatory submission and decision-making\, and ultimately drive commercial success. \nTo learn more and to register online\, visit: https://impacct-rwe.com/
URL:https://www.pharmajournalist.com/event/7th-annual-impacct-rwe/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@impacct-rwe.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190918
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T002214
CREATED:20190613T104247Z
LAST-MODIFIED:20190613T105859Z
UID:21153-1568764800-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual AI-ML Clinical Development Summit
DESCRIPTION:Optimize When & How to Practically Apply AI & Machine Learning to Improve the Efficiency\, Patient Recruitment\, Design and Outcomes of Clinical Trials \nDesigned with leading AI and R&D experts from the likes of GSK\, Pfizer\, Takeda\, Celgene\, AbbVie and academic KOLs\, & containing real world use cases of AI in action\, this year’s AI-ML: Clinical Development Summit tackles both the critical scientific and technical challenges\, as well as identifying opportunities\, of implementing AI and machine learning (ML) to optimize your clinical development. \nThis is a critical time for drug developers to make more data-driven decisions that lead to improved efficacy\, safety and approval outcomes. Only here you will learn when\, strategically\, it is the right time to invest and apply AI to transform your clinical trial success. \nAs clinical failure rates remain unsustainable and the vast amounts of patient data increases further\, AI\, data and clinical development and pharmacovigilance experts from across large pharma and biotech are gathering to discover the growing practical applications of AI and ML. \nWith 60+ thought-leaders converging at the AI-ML Clinical Development Summit\, this will surely be an unrivalled opportunity for you to learn first-hand the growing practical applications of AI and ML. \n\nDiscover how to technically integrate and apply AI algorithms to enhance trial design\, improve patient selection and retention and achieve more precise pharmacovigilance studies.\nGrasp how AI will fundamentally change the paradigm of clinical trial execution and identify key areas where AI can positively impact your drug development decision making.\nHarness AI and extract maximum value to achieve regulatory success and accelerate novel therapeutic products to market.\n\nTo learn more and to register online\, visit: https://ai-clinicaldevelopment.com/
URL:https://www.pharmajournalist.com/event/2nd-annual-ai-ml-clinical-development-summit/
LOCATION:Aloft Boston Seaport District  401-403 D Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@ai-clinicaldevelopment.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190919
DTEND;VALUE=DATE:20190920
DTSTAMP:20260515T002214
CREATED:20190805T111428Z
LAST-MODIFIED:20190805T111428Z
UID:21848-1568851200-1568937599@www.pharmajournalist.com
SUMMARY:2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019
DESCRIPTION:2nd Annual Pharma Packaging\, Labelling\, Serialisation\,\nTrack and Trace 2019\n“Securing your Supply Chain and Quality Management”\n19th September 2019\, Kohinoor Continental Hotel\, Mumbai\, India \n2nd Annual Pharma Packaging\, Labelling\, Serialisation\, Track and Trace 2019 overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems\, this conference addresses serialisation; track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Please contact me on KAVITHA at Email: kavitha@virtueinsight.co.in or Call: +91 9940791115. \nCONFERENCE DELEGATE REGISTRATION: \nIn order to register contact us on E-mail – kavitha@virtueinsight.co.in  Tel: +91 44 24762472 OR M: +91 9940791115 \nPlease note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite\, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.  \n\nEarly Bird Discount Price (Valid until 06th August)  – 1 Delegate – (INR 10\,000 + GST (18%) per delegate) \nStandard Price (Valid From 07th August)  – 1 Delegate – (INR 15\,000 + GST (18%) per delegate) \nFor Bulk Booking of More Than 5 Delegates – Please let us know your interests.\n\nCONFERENCE SPONSORSHIP: \nE-mail – kavitha@virtueinsight.co.in  in Tel: +91 44 24762472 Or M: +91 9940791115 \nSponsor\, Exhibition Stall (Booth) and a paid Speaker Slots are also available. \nWe also have some sponsorship opportunities available for the event\, which gives you an opportunity to sponsor/speak/exhibit\, and create brand awareness. In addition\, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. \n  \nIntroducing the First list of confirmed Speakers  \n\nK. BANGARURAJAN\, Joint Drugs Controller (INDIA)\, CDSCO (HQ)\nRUBINA BOSE\, Deputy Drugs Controller(India)\, CDSCO (WZ)\nMAYUR PARMAR  \, Deputy Collector\, Government Of Gujarat\nSUDHIR MOHAN BANSAL\, Vice President & India Head of Supply Chain Management\, Pfizer\nAMIT KALE\, Associate Vice President – Packaging and Automation\, Reliance\nOMPRAKASH S. SADHWANI\, Former Joint Commissioner and controlling Authority Food and Drug Administration (Maharashtra state)\nCHANDRA SEKHAR\, Vice President Quality\, Reliance Life Sciences\nUDAYKUMAR RAKIBE\, Founder\, PharmaMantra\nVAIBHAV KULKARNI\, Director – Regulatory Affairs\, Abbott Nutrition\nNARESH TONDARE\, Senior Director – National Regulatory Affairs\, Biocon\nSUNIL ACHARYA  \, Packaging Development\, S.C.P.L\nRITESH GOHEL\, Lead\, Global Serialisation and Track & Trace\, Sun Pharma\nS.R.SALUNKHE\, Former Assistant commissioner – FDA Maharashtra\nPRABIR DAS\, Head – Packaging Tech Services\, OSD\, Mylan Laboratories\nSANJAY KUMAR\, Head Of Legal\, Emcure Pharmaceuticals \nSANJAY DAVE\, CCO\, Anfarnd Consultancy Services\nVISHWAS SOVANI\, Founder Director\, Pharmawisdom\nGAURAJ SHAH\, Counsel\, Bombay High Court\nVIRENDRA SINGH\, Senior Manager\, Reliance Life Sciences\nJAGDISH VYAS\, Manager\, Abbott\nRAJSHRI CHETAN PARDESHI\, Manager – New Product & Commercial Packaging Development\, and Sourcing Head for Regulated Market\, Unosource Pharma (An Akums Enterprise)\nDARSHAN VARTAK \, Head Packaging Technical\, Anchor by Panasonic\n\nPlus many more \nWHO SHOULD ATTEND: \nCEO’s\, CTO’s\, CIO’s\, Presidents\, Vice Presidents\, Directors Heads & Managers of: \nPharmaceutical manufacturers and distributors\, Healthcare professionals\, Pharmacists\, Serialisation\, Track and Trace – Solution providers\, Brand – protection\, enforcement\, security\, integrity and management companies\, Drug regulatory agencies\, customs and police\, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection\, Non-governmental organizations (NGOs) active in healthcare\, Patients’ representatives\, Healthcare research organizations\, Pharmaceutical associations\, Anti-counterfeiting organizations\, Packaging\, labeling and converting companies\, Authentication technology suppliers\, Anti-counterfeiting service suppliers – IP specialists\, investigators\, lawyers. \nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time\, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
URL:https://www.pharmajournalist.com/event/2nd-annual-pharma-packaging-labelling-serialisation-track-and-trace-2019/
LOCATION:Kohinoor Continental Hotel\, Mumbai\, India\, Mumbai\, India
ORGANIZER;CN="Virtue Insight":MAILTO:kavitha@virtueinsight.co.in
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190924
DTEND;VALUE=DATE:20190926
DTSTAMP:20260515T002214
CREATED:20180630T165012Z
LAST-MODIFIED:20190607T095126Z
UID:16582-1569283200-1569455999@www.pharmajournalist.com
SUMMARY:The Skin Microbiome Congress Westcoast
DESCRIPTION:The microbiome is set to be one of 2019’s biggest skincare trends\, therefore we are incredibly excited to bring The Skin Microbiome Congress back to San Francisco for the 6th event in our global series. \n \nLast year\, we connected 600+ industry leaders from pharma\, beauty and personal care multinational brands with innovative independent skincare brands\, bio-techs\, researchers and academics who are advancing the skincare industry. This year\, we continue to focus on developing a functional understanding of the skin microbiome\, keeping up with the latest scientific research and competitive intelligence\, as well as focusing on ‘the business of skin microbiome’ – commercializing the trend. \nWHAT MAKES 2019 DIFFERENT? \nNew topics including skin microbiome based-products\, skin conditions\, personalization\, skin-gut supplements\, anti-ageing and commercializing ethically marketed and clinically proven products; as well as presenting the latest academic research – more researchers than ever will be showcasing the latest developments from top universities. \nAlso new for 2019\, we are co-locating with our Microbiome Consumer Nutrition Congress – tailor your agenda and learn about the relationship of skin/gut microbiome and supplements. \nOur 2018 event SOLD OUT\, so make sure you don’t miss out! Download our agenda now. \nTo learn more about The Skin Microbiome Congress WestCoast\, and to register online\, visit https://go.kisacoresearch.com/l/678123/2019-05-30/5hp8 \nContact:\nPhone: +44 (0)203 897 6822\nEmail: mh@kisacoresearch.com
URL:https://www.pharmajournalist.com/event/skin-microbiome-congress-westcoast/
LOCATION:Hotel Kabuki\, 1625 Post St\, San Francisco\, CA\, 94115\, United States
ORGANIZER;CN="Kisaco Research":MAILTO:mh@kisacoresearch.com
END:VEVENT
END:VCALENDAR